Financial PerformanceInteger Holdings reported as-expected financial results for their 3Q25, including revenues of $467.7 million, up 8% year-over-year, and increased adjusted earnings per share of $1.79 as compared to $1.43 one year ago.
Growth PotentialInteger still has roughly $450 million in financial assets available for M&A, and recent Precision Coating and VSi deals have been adding to growth and earnings already this year.
Market OpportunitiesThe cardiovascular device market as a whole is expected to remain strong in the future, driven by new product innovation and favorable demographics, which bodes well for Integer overcoming any near-term bumps in production.